Divergent sodium channel defects in familial hemiplegic migraine

被引:80
作者
Kahlig, Kristopher M.
Rhodes, Thomas H.
Pusch, Michael
Freilinger, Tobias
Pereira-Monteiro, Jose M.
Ferrari, Michel D.
van den Maagdenberg, Arn M. J. M.
Dichgans, Martin
George, Alfred L., Jr.
机构
[1] Vanderbilt Univ, Dept Med, Nashville, TN 37240 USA
[2] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37240 USA
[3] CNR, Inst Biofis, I-16149 Genoa, Italy
[4] Univ Munich, Dept Neurol, D-80539 Munich, Germany
[5] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099002 Oporto, Portugal
[6] Hosp Geral Santo Antonio, Neurol Serv, P-4099001 Oporto, Portugal
[7] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands
关键词
epilepsy; SCN1A; Na(v)1.1; FHM3;
D O I
10.1073/pnas.0711717105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Familial hemiplegic migraine type 3 (FHM3) is a severe autosomal dominant migraine disorder caused by mutations in the voltage-gated sodium channel Na(v)1.1 encoded by SCN1A. We determined the functional consequences of three mutations linked to FHM3 (L263V, Q1489K, and L1649Q) in an effort to identify molecular defects that underlie this inherited migraine disorder. Only L263V and Q1489K generated quantifiable sodium currents when coexpressed in tsA201 cells with the human beta(1) and beta(2) accessory subunits. The third mutant, L1649Q, failed to generate measurable whole-cell current because of markedly reduced cell surface expression. Compared to WT-Na(v)1.1, Q1489K exhibited increased persistent current but also enhanced entry into slow inactivation as well as delayed recovery from fast and slow inactivation, thus resulting in a predominantly loss-of-function phenotype further demonstrated by a greater loss of channel availability during repetitive stimulation. In contrast, L263V exhibited gain-of-function features, including delayed entry into, as well as accelerated recovery from, fast inactivation; depolarizing shifts in the steady-state voltage dependence of fast and slow inactivation; increased persistent current; and delayed entry into slow inactivation. Notably, the two mutations (Q1489K and L1649Q) that exhibited partial or complete loss of function are linked to typical FHM, whereas the gain-of-function mutation L263V occurred in a family having both FHM and a high incidence of generalized epilepsy. We infer from these data that a complex spectrum of Na(v)1.1 defects can cause FHM3. Our results also emphasize the complex relationship between migraine and epilepsy and provide further evidence that both disorders may share common molecular mechanisms.
引用
收藏
页码:9799 / 9804
页数:6
相关论文
共 42 条
[1]   The brain is hyperexcitable in migraine [J].
Aurora, S. K. ;
Wilkinson, F. .
CEPHALALGIA, 2007, 27 (12) :1442-1453
[2]   PI 3-kinase regulation of dopamine uptake [J].
Carvelli, L ;
Morón, JA ;
Kahlig, KM ;
Ferrer, JV ;
Sen, N ;
Lechleiter, JD ;
Leeb-Lundberg, LMF ;
Merrill, G ;
Lafer, EM ;
Ballou, LM ;
Shippenberg, TS ;
Javitch, JA ;
Lin, RZ ;
Galli, A .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (04) :859-869
[3]  
CASTRO MJ, 2008, CEPHALAGIA IN PRESS
[4]   Cocaine increases dopamine uptake and cell surface expression of dopamine transporters [J].
Daws, LC ;
Callaghan, PD ;
Morón, JA ;
Kahlig, KM ;
Shippenberg, TS ;
Javitch, JA ;
Galli, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (05) :1545-1550
[5]   Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2 [J].
De Fusco, M ;
Marconi, R ;
Silvestri, L ;
Atorino, L ;
Rampoldi, L ;
Morgante, L ;
Ballabio, A ;
Aridon, P ;
Casari, G .
NATURE GENETICS, 2003, 33 (02) :192-196
[6]   Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine [J].
Dichgans, M ;
Freilinger, T ;
Eckstein, G ;
Babini, E ;
Lorenz-Depiereux, B ;
Biskup, S ;
Ferrari, MD ;
Herzog, J ;
van den Maagdenberg, AMJM ;
Pusch, M ;
Strom, TM .
LANCET, 2005, 366 (9483) :371-377
[7]   Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2 [J].
Escayg, A ;
MacDonald, BT ;
Meisler, MH ;
Baulac, S ;
Huberfeld, G ;
An-Gourfinkel, I ;
Brice, A ;
LeGuern, E ;
Moulard, B ;
Chaigne, D ;
Buresi, C ;
Malafosse, A .
NATURE GENETICS, 2000, 24 (04) :343-345
[8]   Migraine [J].
Ferrari, MD .
LANCET, 1998, 351 (9108) :1043-1051
[9]   Recent advances in understanding migraine mechanisms, molecules and therapeutics [J].
Goadsby, Peter J. .
TRENDS IN MOLECULAR MEDICINE, 2007, 13 (01) :39-44
[10]  
Gong B, 1999, J COMP NEUROL, V412, P342